Global OTC Artificial Tears Market to Reach US$ 7.8 Billion by 2032, Bolstered by Various Product Innovations

April 18, 2022 | Healthcare

The latest report by IMARC Group, titled “OTC Artificial Tears Market Report by Product (Solution, Ointment, Emulsion, Gel, Spray Solution, Suspensions), Container Type (Plastic Single Dose Container, Plastic Multi-Dose Container, and Others), Formulation (Preservative Based, Non-Preservative Based), Application (Dry Eye Syndrome, Allergies, Infections, UV and Blue Light Protection, Contact Lens Moisture Retention, and Others), Distribution Channel (Hospital Pharmacies, Drug Store and Retail Pharmacies, Online Pharmacies), and Region 2024-2032,” finds that the global OTC artificial tears market reached a value of US$ 5.2 Billion in 2023. Over-the-counter (OTC) artificial tears are lubricant eye drops used to treat dryness and irritation of conjunctiva, cornea, or the entire eye surface, caused by the deficiency of tears production. They aid in initiating natural tears and treating eye disorders like allergy, infection, pain, discomfort, redness, photophobia, and irritation. OTC artificial tears protect the eyes from UV rays and blue light and are also used for moisturizing contact lenses. The artificial tears are manufactured from dextran, glycerin, propylene, glycol, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose. Nowadays, OTC artificial tears are gaining popularity among consumers as they are generally available in ointment, spray, emulsion, solution, and gel forms, which are highly convenient to use.

Global OTC Artificial Tears Market Trends: 

The market is primarily driven by the rising prevalence of dry eye syndrome (DES), diabetes, and nutritional deficiencies among individuals. In addition, the increasing geriatric population prone to chronic eye-related disorders is fueling the market growth. Besides this, the growing penetration of electronic devices, such as smartphones, tablets, televisions, and personal computers, is increasing screen time, which is leading to eye fatigue among people. This, along with the increasing adoption of contact lenses to facilitate the flow of oxygen to the cornea and prevent dryness on the surface of the eyes, is propelling the demand for OTC artificial tears. Furthermore, manufacturers are extensively investing in research and development (R&D) activities and introducing novel approaches for improving OTC artificial tears, including small molecule, biologic, and recombinant technologies, thus creating a positive outlook for the market. Looking forward, the market value is expected to reach US$ 7.8 Billion by 2032, exhibiting a CAGR of 4.58% during the forecast period (2024-2032).

Market Summary: 

  • Based on the product, the market has been segmented into solution, ointment, emulsion, gel, spray solution, and suspensions.
  • On the basis of the container type, the market has been classified into plastic single dose container, plastic multi-dose container, and others.
  • The market has been bifurcated based on the formulation into preservative and non-preservative based formulations.
  • On the basis of the application, the market has been segregated into dry eye syndrome, allergies, infections, UV and blue light protection, contact lens moisture retention and others.
  • Based on the distribution channel, the market has been categorized into hospital pharmacies, drug store and retail pharmacies, and online pharmacies.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined, with some of the key players being AbbVie Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Johnson & Johnson, Nicox S.A., OASIS Medical, OCuSOFT Inc., Santen Pharmaceutical Corporation Limited, Similasan Corporation, Sun Pharmaceutical Industries Limited, and URSAPHARM Arzneimittel GmbH.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global OTC Artificial Tears Market to Reach US$ 7.8 Billion by 2032, Bolstered by Various Product Innovations
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More